Carregant...
Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London
Inhaled corticosteroids (ICS) are often prescribed for worsening breathlessness, exacerbation frequency or lung function in chronic obstructive pulmonary disease (COPD). In mild-moderate disease and infrequent exacerbations, treatment risks may outweigh benefits and ICS may be withdrawn safely under...
Guardat en:
| Publicat a: | NPJ Prim Care Respir Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395712/ https://ncbi.nlm.nih.gov/pubmed/32737296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00191-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|